FDA Warns Against the Use of Unauthorized Devices for Diabetes Management


Today, the U.S. Food and Drug Administration is warning patients and health care professionals of risks associated with the use of unapproved or unauthorized devices for diabetes management, including continuous glucose monitoring systems, insulin pumps and automated insulin dosing systems. In the safety communication issued today, the agency noted that the use of unapproved or unauthorized devices could result in inaccurate blood glucose (sugar) measurements or unsafe insulin dosing, which can lead to injury requiring medical intervention or even death.

Previous Article

Doctors can estimate patient adherence by simply asking about medication routine

Next Article

HHS Report on Pain Management Best Practices: Updates, Gaps, Inconsistencies, and Recommendations